Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Dec 15, 2024; 16(12): 4625-4635
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4625
Figure 1
Figure 1 Flowchart of the cohort included in the analysis. HCC: Hepatocellular carcinoma.
Figure 2
Figure 2 Distribution of etiology. HBV: Hepatitis B virus; HCV: Hepatitis C virus; AC: Alcohol-associated cirrhosis; MASLD: Metabolic dysfunction-associated liver disease; PBC: Primary biliary cirrhosis.
Figure 3
Figure 3 Incidence of hepatocellular carcinoma in cirrhotic patients with different etiologies. A and C: Child-Pugh grades; B and D: Mean time to occurrence. HBV: Hepatitis B virus; HCV: Hepatitis C virus; AC: Alcohol-associated cirrhosis; MASLD: Metabolic dysfunction-associated liver disease; PBC: Primary biliary cirrhosis.
Figure 4
Figure 4 Cumulative incidence curves for overall hepatocellular carcinoma. A: Mortality; B: Sex; C: Age; D: Etiology. HBV: Hepatitis B virus; HCV: Hepatitis C virus; HCC: Hepatocellular carcinoma.